Form 4 for TPB Turning Point Brands, Inc.
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-19 · accession 0001437749-25-038754 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-23 | 2025-12-19 | TPB | Glazek David Edward | Executive COB, Dir | S - Sale+OE | $110.26 | -30.0K | 127.1K | -19% | -$3.31M |
| D | 2025-12-23 | 2025-12-19 | TPB | Glazek David Edward | Executive COB, Dir | M - OptEx | $20.71 | +30.0K | 157.1K | +24% | +$621.3K |
| D | 2025-12-23 | 2025-12-19 | TPB | Glazek David Edward | Executive COB, Dir | J - Other | — | +78.0K | 78.0K | New | — |
| D | 2025-12-23 | 2025-12-19 | TPB | Glazek David Edward | Executive COB, Dir | M - OptEx | $20.71 | -30.0K | 47.5K | -39% | -$621.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-19 | S | D | 30,000 | $110.26 | 127,083 | D | — | — | (F2) The reported transaction involves the sale of 30,000 shares of common stock received upon exercise of the options described in footnote 1. |
| 2 | Common | Common Stock | 2025-12-19 | M | A | 30,000 | $20.71 | 157,083 | D | — | — | (F1) The reported transaction involved the reporting person's exercise of 30,000 options granted under 2021 Equity Incentive Plan. The total reported in Column 5 includes 35,956 restricted stock units and 91,127 shares of common stock. |
| 3 | Derivative | Forward contract | 2025-12-19 | J | A | 78,000 | — | 78,000 | D | — · — to — | 78,000 Common Stock | (F4) On December 19, 2025, the reporting person revised a previously disclosed financing transaction with an unaffiliated dealer dated June 4, 2025 that had the effect of canceling the transaction initially contemplated by the contract and commencing a new transaction to reflect the current stock price and extend the duration of the contract. Under the revised financing the reporting person receives a gross amount of approximately $7.0 million and continues to pledge up to 78,000 shares of the issuer's common stock (the "Pledged Shares"). (F5) On the revised maturity date of December 19, 2027 the reporting person is obligated to repay the lender in cash or at the reporting person's election to deliver up to 78,000 shares of the Issuer's common stock at a price per share ranging from $105.33 to $126.39 based on the then prevailing market price. The reporting person retains beneficial ownership of the Pledged Shares, including dividend and voting rights. The revised financing transaction was completed at a price per share of $110.87. |
| 4 | Derivative | Options | 2025-12-19 | M | D | 30,000 | $20.71 | 47,519 | D | $20.71 · — to 2033-05-12 | 77,519 Common Stock | (F1) The reported transaction involved the reporting person's exercise of 30,000 options granted under 2021 Equity Incentive Plan. The total reported in Column 5 includes 35,956 restricted stock units and 91,127 shares of common stock. |